Shares for Therapeutics Acquisition Corp., a blank check company targeting biotechnology enterprises in the health care industry, began trading Wednesday in an upsized $118 million initial public offering advised on by Goodwin led by Technology partner Jocelyn Arel and counsel Daniel Espinoza. Read the article in Law360 here.